HEMISPHERX BIOPHARMA INC's ticker is HEB and the CUSIP is 42366C301. A total of 20 filers reported holding HEMISPHERX BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $3,000 | 0.0% | 15,834 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $3,000 | -25.0% | 15,834 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $4,000 | -20.0% | 15,834 | 0.0% | 0.00% | -33.3% |
| Q2 2018 | $5,000 | -16.7% | 15,834 | 0.0% | 0.00% | 0.0% |
| Q1 2018 | $6,000 | +20.0% | 15,834 | 0.0% | 0.00% | 0.0% |
| Q4 2017 | $5,000 | 0.0% | 15,834 | 0.0% | 0.00% | 0.0% |
| Q3 2017 | $5,000 | -37.5% | 15,834 | 0.0% | 0.00% | -40.0% |
| Q2 2017 | $8,000 | -11.1% | 15,834 | 0.0% | 0.01% | -16.7% |
| Q1 2017 | $9,000 | -18.2% | 15,834 | 0.0% | 0.01% | -25.0% |
| Q4 2016 | $11,000 | -45.0% | 15,834 | 0.0% | 0.01% | -50.0% |
| Q3 2016 | $20,000 | – | 15,834 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Anson Funds Management LP | 1,071,627 | $739,000 | 0.23% |
| SABBY MANAGEMENT, LLC | 1,391,286 | $960,000 | 0.06% |
| Occidental Asset Management, LLC | 15,834 | $11,000 | 0.01% |
| Waldron Private Wealth LLC | 11,000 | $7,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 80 | $0 | 0.00% |
| BLACKROCK ADVISORS LLC | 5,727 | $4,000 | 0.00% |
| UBS Group AG | 10,200 | $7,000 | 0.00% |
| CITY HOLDING CO | 417 | $0 | 0.00% |
| NORTHERN TRUST CORP | 17,111 | $11,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 74,832 | $51,000 | 0.00% |